论文部分内容阅读
作者认为曼氏血吸虫病锑剂治疗的长期疗效仍属疑问,因此对60年代初期30例瑞典人在扎伊尔感染曼氏血吸虫回国用巯醇锑治疗后的疗效进行了随访。这些患者在去扎伊尔之前未曾到过任何血吸虫病流行区。其中13例是在扎伊尔感染血吸虫后几个月内经诊断并加以治疗的“早期”血吸虫病人,其中除1例外全无症状。余17例为感染时间较长的“晚期”病人,这些患者有很多症状,化验结果亦不同于上述的“早期”病人。这
The author believes that the long-term efficacy of antimony treatment of Schistosoma mansoni remains questionable and therefore the efficacy of 30 Swedish patients in the early 60’s after the return of ZA-infected Schistosoma mansoni with antimony sulfoxide was followed up. These patients have not been to any endemic area of schistosomiasis before they went to Zaire. Thirteen of these were “early” schistosomiasis diagnosed and treated within a few months after Zoel infections of the schistosomes, with the exception of one being asymptomatic. The remaining 17 patients were “late” patients with longer infection times. These patients had many symptoms and the test results were also different from the “early” patients described above. This